» Authors » Anat Mirelman

Anat Mirelman

Explore the profile of Anat Mirelman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 227
Citations 5982
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mancini M, Hausdorff J, Pelosin E, Bonato P, Camicioli R, Ellis T, et al.
J Parkinsons Dis . 2025 Feb; :1877718X241305626. PMID: 40007168
Background: Research over the past twenty years has shown that gait outcomes have a high sensitivity for diagnosing Parkinson's disease (PD), for detecting the effects of interventions, and for monitoring...
2.
Dagay A, Katzav S, Wasserman D, Gnoni V, Mirelman A, Tauman R
Ann Neurol . 2025 Feb; PMID: 39981867
Objective: The objective of this study was to investigate the differences in cyclic alternating patterns (CAP) metrics, a non-rapid eye movement (NREM) sleep physiological rhythm, among recently diagnosed patients with...
3.
Goldstein O, Shani S, Gana-Weisz M, Elkoshi N, Casey F, Sun Y, et al.
J Parkinsons Dis . 2025 Feb; :1877718X241310722. PMID: 39973498
Background: While and variants are associated with Parkinson's disease (PD), most carriers will not develop the disease. Objective: To test if polygenic risk score (PRS) modifies disease risk and phenotypes...
4.
Shani S, Gana-Weisz M, Bar-Shira A, Thaler A, Gurevich T, Mirelman A, et al.
J Parkinsons Dis . 2025 Feb; 14(8):1575-1583. PMID: 39957192
Background: The adaptive immune response has a role in Parkinson's disease (PD). Patients with or mutations often exhibit distinct clinical characteristics. Objective: To evaluate the involvement of adaptive immune response...
5.
Sosnik R, Fahoum F, Katzir Z, Mirelman A, Maidan I
NPJ Parkinsons Dis . 2025 Jan; 11(1):2. PMID: 39753579
We aimed to study the effect of Parkinson's disease (PD) and motor-cognitive load on the interplay between activation level and spatial complexity. To that end, 68 PD patients and 30...
6.
Droby A, Yoffe-Vasiliev A, Atias D, Fraser K, Mabrouk O, Omer N, et al.
NPJ Parkinsons Dis . 2025 Jan; 11(1):7. PMID: 39753572
Alpha-synuclein (αS) aggregation is a widely regarded hallmark of Parkinson's disease (PD) and can be detected through synuclein amplification assays (SAA). This study investigated the association between cerebrospinal fluid (CSF)...
7.
Peleg O, Soret R, Charras P, Peysakhovich V, Mirelman A, Levy D, et al.
J Geriatr Psychiatry Neurol . 2024 Dec; :8919887241311170. PMID: 39714145
Switching, a critical executive function, can manifest as task switching (TS) or response switching (RS). Although TS impairments in Parkinson's disease (PD) are well-studied, RS, especially in contexts requiring adaptive...
8.
Possti D, Oz S, Gerston A, Wasserman D, Duncan I, Cesari M, et al.
NPJ Digit Med . 2024 Nov; 7(1):341. PMID: 39609533
Polysomnography, the gold standard diagnostic tool in sleep medicine, is performed in an artificial environment. This might alter sleep and may not accurately reflect typical sleep patterns. While macro-structures are...
9.
Khanna A, Adams J, Antoniades C, Bloem B, Carroll C, Cedarbaum J, et al.
NPJ Parkinsons Dis . 2024 Nov; 10(1):225. PMID: 39567515
Parkinson's Disease is a progressive neurodegenerative disorder afflicting almost 12 million people. Increased understanding of its complex and heterogenous disease pathology, etiology and symptom manifestations has resulted in the need...
10.
Zifman N, Levy-Lamdan O, Hiller T, Thaler A, Dolev I, Mirelman A, et al.
NPJ Parkinsons Dis . 2024 Sep; 10(1):182. PMID: 39349492
Distinguishing Parkinson's disease (PD) subgroups may be achieved by observing network responses to external stimuli. We compared TMS-evoked potential (TEP) measures from stimulation of bilateral motor cortex (M1), dorsolateral prefrontal...